Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine] in Pregnant Women

NCT05457894 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

207

Enrollment

OTHER_GOV

Sponsor class

Conditions

Influenza, Human
Vaccination; Infection
Vaccines

Interventions

BIOLOGICAL: Flu-M, Inactivated split influenza vaccine
BIOLOGICAL: Ultrix®, Inactivated Split Influenza Vaccine

Sponsor

St. Petersburg Research Institute of Vaccines and Sera